- Home
- NIU vs TIL Comparison
NIU vs TIL Comparison
Compare NIU & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- TIL
- Stock Information
- Founded
- NIU 2014
- TIL 2018
- Country
- NIU China
- TIL United States
- Employees
- NIU N/A
- TIL N/A
- Industry
- NIU Auto Manufacturing
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- TIL Health Care
- Exchange
- NIU Nasdaq
- TIL Nasdaq
- Market Cap
- NIU 216.7M
- TIL 230.1M
- IPO Year
- NIU 2018
- TIL 2021
- Fundamental
- Price
- NIU $3.51
- TIL $27.56
- Analyst Decision
- NIU
- TIL Buy
- Analyst Count
- NIU 0
- TIL 5
- Target Price
- NIU N/A
- TIL $119.00
- AVG Volume (30 Days)
- NIU 1.2M
- TIL 510.3K
- Earning Date
- NIU 08-11-2025
- TIL 08-12-2025
- Dividend Yield
- NIU N/A
- TIL N/A
- EPS Growth
- NIU N/A
- TIL N/A
- EPS
- NIU N/A
- TIL N/A
- Revenue
- NIU $477,578,753.00
- TIL N/A
- Revenue This Year
- NIU $41.32
- TIL N/A
- Revenue Next Year
- NIU $24.38
- TIL N/A
- P/E Ratio
- NIU N/A
- TIL N/A
- Revenue Growth
- NIU 26.51
- TIL N/A
- 52 Week Low
- NIU $1.65
- TIL $9.62
- 52 Week High
- NIU $4.90
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- NIU 49.77
- TIL 51.84
- Support Level
- NIU $3.12
- TIL $27.01
- Resistance Level
- NIU $3.93
- TIL $42.79
- Average True Range (ATR)
- NIU 0.21
- TIL 5.01
- MACD
- NIU 0.01
- TIL -1.00
- Stochastic Oscillator
- NIU 48.15
- TIL 9.82
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.